Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.
2.

Inhibition by somatostatin of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.

Nakaizumi A, Uehara H, Baba M, Iishi H, Tatsuta M.

Carcinogenesis. 1993 Dec;14(12):2601-4.

PMID:
7903604
3.

Inhibition by verapamil of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.

Uehara H, Nakaizumi A, Baba M, Iishi H, Tatsuta M.

Br J Cancer. 1993 Jul;68(1):37-40.

4.

Suppression by pravastatin, an inhibitor of p21ras isoprenylation, of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.

Tatsuta M, Iishi H, Baba M, Iseki K, Yano H, Uehara H, Yamamoto R, Nakaizumi A.

Br J Cancer. 1998 Feb;77(4):581-7.

5.

Suppression by Chai-hu-gui-zhi-tang of the development of liver lesions induced by N-nitrosomorpholine in Sprague-Dawley rats.

Tatsuta M, Iishi H, Baba M, Narahara H, Yano H, Sakai N.

Cancer Lett. 2000 Apr 28;152(1):31-6.

PMID:
10754203
6.

Inhibition by the calmodulin antagonist trifluoperazine of experimental hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.

Tatsuta M, Iishi H, Baba M, Yano H, Uehara H, Nakaizumi A, Iseki K.

Cancer Lett. 1996 Oct 22;107(2):179-85.

PMID:
8947510
8.

Enhancement by isoproterenol of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.

Uehara H, Nakaizumi A, Baba M, Iishi H, Tatsuta M.

Int J Cancer. 1993 Feb 20;53(4):703-6.

PMID:
8382197
9.

Inhibition by xiao-chai-hu-tang (TJ-9) of development of hepatic foci induced by N-nitrosomorpholine in Sprague-Dawley rats.

Tatsuta M, Iishi H, Baba M, Nakaizumi A, Uehara H.

Jpn J Cancer Res. 1991 Sep;82(9):987-92.

PMID:
1682293
10.

Failure to demonstrate chemoprevention by the monoterpene perillyl alcohol during early rat hepatocarcinogenesis: a cautionary note.

Löw-Baselli A, Huber WW, Käfer M, Bukowska K, Schulte-Hermann R, Grasl-Kraupp B.

Carcinogenesis. 2000 Oct;21(10):1869-77.

11.

Inhibition of liver glutathione S-transferase placental form-positive foci development in the rat hepatocarcinogenesis by Porphyra tenera (Asakusa-nori).

Ichihara T, Wanibuchi H, Taniyama T, Okai Y, Yano Y, Otani S, Imaoka S, Funae Y, Fukushima S.

Cancer Lett. 1999 Jul 1;141(1-2):211-8.

PMID:
10454264
12.

Enhancement by ethyl alcohol of experimental hepatocarcinogenesis induced by N-nitrosomorpholine.

Tatsuta M, Iishi H, Baba M, Yano H, Iseki K, Uehara H, Nakaizumi A.

Int J Cancer. 1997 Jun 11;71(6):1045-8.

13.

Chemoprevention by amiloride against experimental hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.

Tatsuta M, Iishi H, Baba M, Yano H, Sakai N, Uehara H, Nakaizumi A.

Cancer Lett. 1997 Oct 28;119(1):109-13.

PMID:
18372529
14.

Enhancement by neurotensin of hepatocarcinogenesis by N-nitrosomorpholine in Sprague-Dawley rats.

Nakaizumi A, Uehara H, Baba M, Iishi H, Tatsuta M.

Cancer Lett. 1996 Dec 20;110(1-2):57-61.

PMID:
9018081
15.
16.

Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in N-nitrosodiethylamine-induced preneoplastic nodules in rats.

Khan MS, Devaraj H, Devaraj N.

Toxicol Appl Pharmacol. 2011 Feb 15;251(1):85-94. doi: 10.1016/j.taap.2010.12.004.

PMID:
21167192
17.

Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.

Fujii Y, Segawa R, Kimura M, Wang L, Ishii Y, Yamamoto R, Morita R, Mitsumori K, Shibutani M.

Chem Biol Interact. 2013 Sep 25;205(2):108-18. doi: 10.1016/j.cbi.2013.06.017.

PMID:
23830814
18.

Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model.

Chakraborty T, Chatterjee A, Saralaya MG, Dhachinamoorthi D, Chatterjee M.

Life Sci. 2006 May 8;78(24):2839-51.

PMID:
16352317
19.
Items per page

Supplemental Content

Support Center